Cargando…

Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector

OBJECTIVE: The transformation in cells at genetic levels stimulatesthe proliferation of cancer. The current review highlights the role of miRNA in management of cancer by altering processes of body at cellular levels. METHODS: A deep research on the literature available till date for miRNA in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Behl, Tapan, Kumar, Chanchal, Makkar, Rashita, Gupta, Amit, Sachdeva, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437313/
https://www.ncbi.nlm.nih.gov/pubmed/32212783
http://dx.doi.org/10.31557/APJCP.2020.21.3.593
_version_ 1783572611357212672
author Behl, Tapan
Kumar, Chanchal
Makkar, Rashita
Gupta, Amit
Sachdeva, Monika
author_facet Behl, Tapan
Kumar, Chanchal
Makkar, Rashita
Gupta, Amit
Sachdeva, Monika
author_sort Behl, Tapan
collection PubMed
description OBJECTIVE: The transformation in cells at genetic levels stimulatesthe proliferation of cancer. The current review highlights the role of miRNA in management of cancer by altering processes of body at cellular levels. METHODS: A deep research on the literature available till date for miRNA in cancer was conducted using various medical sites like PubMed, MEDLINE from internet and data was collected. The articles were majorly preferred in English language. RESULTS: The development of normal cells into cancerous cells is a multivalent procedure highlighting numerous responsible factors. During the progression of cancer, the role of oncogene and tumor suppressor genes outshines at different levels of tumorogenesis. Metastasis poses highest threat in cancer progression and fabricates obstacles to clinicians and researchers in preventing formation of tumor on secondary sites. The mesenchymal-epithelial transition (MET) and epithelial mesenchymal transition (EMT) induce dissemination and ultimately progression of cancer. CONCLUSION: A comprehensive knowledge of the altered genes and the mechanism by which they induce formation of tumor is essential as they contribute in proliferating cancer at various stages, aggravating clinical symptoms. Hence miRNAs can be efficiently employed as an emerging treatment therapy for cancer.
format Online
Article
Text
id pubmed-7437313
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-74373132020-09-02 Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector Behl, Tapan Kumar, Chanchal Makkar, Rashita Gupta, Amit Sachdeva, Monika Asian Pac J Cancer Prev Review Article OBJECTIVE: The transformation in cells at genetic levels stimulatesthe proliferation of cancer. The current review highlights the role of miRNA in management of cancer by altering processes of body at cellular levels. METHODS: A deep research on the literature available till date for miRNA in cancer was conducted using various medical sites like PubMed, MEDLINE from internet and data was collected. The articles were majorly preferred in English language. RESULTS: The development of normal cells into cancerous cells is a multivalent procedure highlighting numerous responsible factors. During the progression of cancer, the role of oncogene and tumor suppressor genes outshines at different levels of tumorogenesis. Metastasis poses highest threat in cancer progression and fabricates obstacles to clinicians and researchers in preventing formation of tumor on secondary sites. The mesenchymal-epithelial transition (MET) and epithelial mesenchymal transition (EMT) induce dissemination and ultimately progression of cancer. CONCLUSION: A comprehensive knowledge of the altered genes and the mechanism by which they induce formation of tumor is essential as they contribute in proliferating cancer at various stages, aggravating clinical symptoms. Hence miRNAs can be efficiently employed as an emerging treatment therapy for cancer. West Asia Organization for Cancer Prevention 2020-03 /pmc/articles/PMC7437313/ /pubmed/32212783 http://dx.doi.org/10.31557/APJCP.2020.21.3.593 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Behl, Tapan
Kumar, Chanchal
Makkar, Rashita
Gupta, Amit
Sachdeva, Monika
Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
title Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
title_full Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
title_fullStr Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
title_full_unstemmed Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
title_short Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
title_sort intercalating the role of micrornas in cancer: as enemy or protector
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437313/
https://www.ncbi.nlm.nih.gov/pubmed/32212783
http://dx.doi.org/10.31557/APJCP.2020.21.3.593
work_keys_str_mv AT behltapan intercalatingtheroleofmicrornasincancerasenemyorprotector
AT kumarchanchal intercalatingtheroleofmicrornasincancerasenemyorprotector
AT makkarrashita intercalatingtheroleofmicrornasincancerasenemyorprotector
AT guptaamit intercalatingtheroleofmicrornasincancerasenemyorprotector
AT sachdevamonika intercalatingtheroleofmicrornasincancerasenemyorprotector